NO880929D0 - Produksjon og bruk av il-6. - Google Patents

Produksjon og bruk av il-6.

Info

Publication number
NO880929D0
NO880929D0 NO88880929A NO880929A NO880929D0 NO 880929 D0 NO880929 D0 NO 880929D0 NO 88880929 A NO88880929 A NO 88880929A NO 880929 A NO880929 A NO 880929A NO 880929 D0 NO880929 D0 NO 880929D0
Authority
NO
Norway
Prior art keywords
production
hematopoietins
deficiencies
peptide
useful
Prior art date
Application number
NO88880929A
Other languages
English (en)
Other versions
NO176665B (no
NO176665C (no
NO880929L (no
Inventor
Steven C Clark
Gordon G Wong
Paul Schendel
John Mccoy
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27367237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO880929(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of NO880929D0 publication Critical patent/NO880929D0/no
Publication of NO880929L publication Critical patent/NO880929L/no
Publication of NO176665B publication Critical patent/NO176665B/no
Publication of NO176665C publication Critical patent/NO176665C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO880929A 1986-07-08 1988-03-02 Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav NO176665C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88320786A 1986-07-08 1986-07-08
US88590586A 1986-07-15 1986-07-15
US4795787A 1987-05-08 1987-05-08
PCT/US1987/001611 WO1988000206A1 (en) 1986-07-08 1987-07-07 Production and use of il-6

Publications (4)

Publication Number Publication Date
NO880929D0 true NO880929D0 (no) 1988-03-02
NO880929L NO880929L (no) 1988-03-02
NO176665B NO176665B (no) 1995-01-30
NO176665C NO176665C (no) 1995-05-10

Family

ID=27367237

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880929A NO176665C (no) 1986-07-08 1988-03-02 Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav

Country Status (18)

Country Link
EP (2) EP0316319B1 (no)
JP (1) JP2664698B2 (no)
KR (1) KR960013601B1 (no)
AT (2) ATE124959T1 (no)
AU (1) AU615630B2 (no)
CA (1) CA1341355C (no)
DE (2) DE3751406T2 (no)
DK (1) DK173279B1 (no)
ES (1) ES2006776A6 (no)
GR (1) GR871027B (no)
IE (1) IE67035B1 (no)
IL (1) IL83137A (no)
MY (1) MY102865A (no)
NO (1) NO176665C (no)
PL (1) PL159182B1 (no)
PT (1) PT85285B (no)
SK (1) SK279144B6 (no)
WO (1) WO1988000206A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
EP0220574B2 (en) * 1985-10-14 2000-04-12 Yeda Research And Development Company Limited Human interferon beta2A, vectors containing genes coding for said interferon, cell lines producing same
JP2648860B2 (ja) * 1986-05-08 1997-09-03 イエダ リサーチ アンド デベロップメント コンパニー リミテッド ヒトインターフエロン−β２Ａ及びヒトインターフエロン−β２Ｂ、該インターフエロンをコードする遺伝子を含むベクター、該インターフエロンを産生するセルライン及び該インターフエロンの医薬品としての用途
JP2676336B2 (ja) * 1986-08-06 1997-11-12 忠三 岸本 ヒトｂ細胞分化因子の遺伝子
EP0585957A1 (en) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
JPS6356291A (ja) * 1986-08-27 1988-03-10 Chuzo Kishimoto リコンビナントｂｃｄｆ
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
CA1341588C (en) * 1988-01-26 2009-01-06 Michel Revel Human ifn-beta2/i1-6, its purification and use
IL85204A0 (en) * 1988-01-26 1988-07-31 Yeda Res & Dev Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
JPH022353A (ja) * 1988-03-10 1990-01-08 Tosoh Corp ヒトｂ細胞分化因子の製造法
JPH022354A (ja) * 1988-03-31 1990-01-08 Tosoh Corp ヒトｂ細胞分化因子の製造法
GB2217327B (en) * 1988-04-12 1992-01-29 British Bio Technology Synthetic interleukin-6 gene
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5646015A (en) * 1988-08-31 1997-07-08 Astra Ab Excretion of heterologous proteins from E. coli
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
JPH0372429A (ja) * 1988-10-07 1991-03-27 Chugai Pharmaceut Co Ltd 血小板減少症の治療剤
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
JPH0331215A (ja) * 1989-06-27 1991-02-12 Ajinomoto Co Inc 制癌療法支持剤
DE3939706C1 (no) * 1989-12-01 1991-03-21 Centre Regional De Transfusion Sanguine, Besancon, Fr
JPH04218000A (ja) * 1990-02-13 1992-08-07 Kirin Amgen Inc 修飾ポリペプチド
DK0547223T3 (da) * 1990-08-31 1997-02-10 Santen Pharmaceutical Co Ltd Middel mod hornhindelidelser
AU1554592A (en) * 1991-04-18 1992-11-17 Toray Industries, Inc. Interleukin 6 composition and production thereof
US5641868A (en) * 1991-04-18 1997-06-24 Toray Industries, Inc. Interlekin-6 compositions, and a production process thereof
ZA924674B (en) * 1991-07-02 1993-04-28 Imclone Systems Inc Cysteine depleted il-6 mutein
US5338833A (en) * 1992-07-23 1994-08-16 The University Of North Carolina At Chapel Hill Carboxy terminal IL-6 muteins
US5338834A (en) * 1993-01-26 1994-08-16 Allelix Biopharmaceuticals Inc. Ultrapure human interleukin-6
WO1994028919A1 (fr) * 1993-06-08 1994-12-22 Ajinomoto Co., Inc. Accelerateur de la proliferation des cellules hematopietiques
US5599536A (en) * 1993-12-13 1997-02-04 Sandoz Ltd. Method for suppressing the acute phase response in a patient receiving IL-6 therapy
US5578301A (en) * 1993-12-14 1996-11-26 Sandoz Ltd. Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
US5641657A (en) * 1994-05-19 1997-06-24 Human Genome Sciences, Inc. DNA encoding an interleukin-6 splice variant
EP0721780A3 (en) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for promoting platelet and/or leukocyte production
EP0912742A1 (en) * 1996-07-19 1999-05-06 Dade Behring Marburg GmbH Viral interleukin-6
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US7479540B1 (en) 2003-12-22 2009-01-20 Chandan Prasad Adipomodulin and related molecules and methods
JP2008532490A (ja) * 2005-02-15 2008-08-21 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
ES2302402B1 (es) * 2005-06-16 2009-05-08 Proyecto De Biomedicina Cima, S.L. Uso de una citoquina de la familia de interleuquina-6 en la preparacion de una composicion para administracion combinada con interferon-alfa.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein
EP0220574B2 (en) * 1985-10-14 2000-04-12 Yeda Research And Development Company Limited Human interferon beta2A, vectors containing genes coding for said interferon, cell lines producing same
EP0585957A1 (en) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor

Also Published As

Publication number Publication date
NO176665B (no) 1995-01-30
DK173279B1 (da) 2000-06-05
DE3751922D1 (de) 1996-11-14
ATE143811T1 (de) 1996-10-15
DE3751406D1 (de) 1995-08-17
NO176665C (no) 1995-05-10
EP0316319A1 (en) 1989-05-24
DK121788A (da) 1988-03-07
NO880929L (no) 1988-03-02
DE3751406T2 (de) 1995-12-21
ES2006776A6 (es) 1989-05-16
KR880701736A (ko) 1988-11-04
EP0574955A1 (en) 1993-12-22
CA1341355C (en) 2002-04-09
MY102865A (en) 1993-03-31
PT85285B (pt) 1990-03-30
IE67035B1 (en) 1996-02-21
PL266680A1 (en) 1988-07-07
PL159182B1 (pl) 1992-11-30
PT85285A (en) 1987-08-01
JP2664698B2 (ja) 1997-10-15
WO1988000206A1 (en) 1988-01-14
EP0316319B1 (en) 1995-07-12
SK515087A3 (en) 1998-07-08
AU615630B2 (en) 1991-10-10
KR960013601B1 (ko) 1996-10-09
ATE124959T1 (de) 1995-07-15
AU7696287A (en) 1988-01-29
GR871027B (en) 1987-11-02
DK121788D0 (da) 1988-03-07
IL83137A (en) 1995-05-26
EP0574955B1 (en) 1996-10-09
JPH01503354A (ja) 1989-11-16
SK279144B6 (sk) 1998-07-08
IE871726L (en) 1988-01-08
DE3751922T2 (de) 1997-04-03
EP0316319A4 (en) 1989-08-09

Similar Documents

Publication Publication Date Title
NO880929L (no) Produksjon og bruk av il-6.
PH25120A (en) Replicable expression vehicle and process of preparation thereof
MY101209A (en) Production of m-csf.
AU2881389A (en) Human ifn-beta 2/il-6, its purification and use
DE68929167D1 (de) Genexpressions-Elemente und Herstellung von chimären Maus-Mensch-Antikörpern
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
DE69314754D1 (de) Vorläufer B-Zelle stimulierender Faktor
DE3853886D1 (de) Menschliche, erythroid-spezifische transkriptionsenhancer.
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
IL90719A0 (en) Novel nuclei acids and polypeptides encoded thereby
ZA857721B (en) Process for treatment of rheumatic diseases
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
ATE92333T1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
NO900121L (no) Probursin.
AU92306S (en) Buddha figurine
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
IT8748444A0 (it) L'impiego in terapeutica dell'uro chinasi insieme con la pro-urochinasi
AU100583S (en) Aquarium-birdcage combination
AU98542S (en) Bat
IT8919307A0 (it) Produzione di vincamina e di epivincamina mediante colture di cellule di vinca minor.
ATE141104T1 (de) Gentechnische herstellung von protein pp 15.